Evaluation of Performance Status and Hematopoietic Cell Transplantation Specific Comorbidity Index on Unplanned Admission Rates in Patients with Multiple Myeloma Undergoing Outpatient Autologous Stem Cell Transplantation.

Abstract

Although outpatient autologous stem cell transplantation (ASCT) is safe and feasible in most instances, some patients undergoing planned outpatient transplantation for multiple myeloma (MM) will need inpatient admission for transplantation-related complications. We aim to evaluate the difference, if any, between outpatient and inpatient ASCT cohorts of MM… (More)
DOI: 10.1016/j.bbmt.2017.06.001

Topics

Cite this paper

@article{Obiozor2017EvaluationOP, title={Evaluation of Performance Status and Hematopoietic Cell Transplantation Specific Comorbidity Index on Unplanned Admission Rates in Patients with Multiple Myeloma Undergoing Outpatient Autologous Stem Cell Transplantation.}, author={Cynthia Obiozor and Dipti P. Subramaniam and Clint L. Divine and Leyla Shune and Anurag K. Singh and Tara L Lin and Sunil Abhyankar and Guoqing Chen and Joseph McGuirk and Siddhartha S. Ganguly}, journal={Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation}, year={2017}, volume={23 10}, pages={1641-1645} }